|
2025
|
Invention
|
Her2-binding polypeptide. The present disclosure concerns a new polypeptide and fusion proteins w... |
|
2024
|
Invention
|
Methods of treatment of psoriatic arthritis. The invention related to methods of treatment of pso... |
|
|
Invention
|
Methods of treatment of uveitis. The disclosure related to methods of treatment of uveitis. In ce... |
|
|
Invention
|
Methods of treating hidradenitis suppurativa. The disclosure relates to novel regimens for treati... |
|
|
Invention
|
Il-17a-binding polypeptides.
The present disclosure relates to a class of engineered polypeptide... |
|
|
Invention
|
New polypeptide. 347101116171820212526293030 or a sequence having at least 93 % identity thereto.... |
|
2023
|
P/S
|
Chemical substances and materials for industrial, scientific and laboratory use other than for me... |
|
|
P/S
|
Chemical substances and materials for industrial, scientific
and laboratory use; chemical reagen... |
|
|
P/S
|
Chemical substances and materials for industrial, scientific and laboratory use; chemical reagent... |
|
|
Invention
|
Protein z variants binding thymic stromal lymphopoietin and their medical use. 471116171820212526... |
|
2022
|
P/S
|
Chemical substances, chemical materials and chemical preparations, and natural elements; chemical... |
|
|
Invention
|
New her2-binding polypeptide.
A HER2-binding polypeptide is provided, comprising the amino acid ... |
|
|
Invention
|
New her2-binding polypeptide. A HER2-binding polypeptide is provided, comprising the amino acid s... |
|
|
Invention
|
Method for reducing the immune response to a biologically active protein.
A new use of a molecul... |
|
2021
|
Invention
|
New polypeptide.
The present disclosure relates to a class of engineered polypeptides having a b... |
|
|
Invention
|
New polypeptide. 2346710 1116171821252626LKD. The present disclosure also relates to the use of s... |
|
|
P/S
|
Chemical substance preparations, chemical materials preparations and chemical preparations all fo... |
|
|
P/S
|
Chemical substances, chemical materials and chemical
preparations, and chemical elements; chemic... |
|
|
P/S
|
Chemicals used in industry and science; chemical reagents
(other than for medical or veterinary ... |
|
|
P/S
|
Chemicals used in industry, namely for the manufacture of pharmaceuticals, biopharmaceuticals; Bi... |
|
|
Invention
|
Methods of treatment of il-17a associated conditions. 29. Also disclosed is the use of such an in... |
|
2020
|
Invention
|
Her2 binders. Imaging agents comprising an isolated polypeptide conjugated with a radionucleide a... |
|
|
Invention
|
New process of extracting protein.
A method of extracting a cytoplasmic or periplasmic protein. ... |
|
|
Invention
|
New process of extracting protein. A method of extracting a cytoplasmic or periplasmic protein. T... |
|
|
Invention
|
Polypeptides.
The present disclosure relates to a class of engineered polypeptides having a bind... |
|
|
Invention
|
Polypeptides. 23467101116171820212626LED or a sequence having at least 93 % identity thereto. The... |
|
2019
|
Invention
|
Neonatal fc receptor binding dimer and methods of use.
The present disclosure relates to dimers ... |
|
|
Invention
|
Polypeptides based on a scaffold. sc4XA XXVEXVQXXK QXILAX. The disclosure also provides methods f... |
|
|
Invention
|
Polypeptides based on a novel scaffold. sc1sc2sc3sc4sc4XA XXVEXVQXXK QXILAX. The disclosure also ... |
|
2018
|
Invention
|
Oral administration.
The present invention is within the field of administration of biopharmaceu... |
|
|
Invention
|
Her2 binders. Imaging agents comprising an isolated polypeptide conjugated with a radionuclide an... |
|
2017
|
Invention
|
Polypeptides. 29. The present disclosure also relates to the use of such an FcRn binding polypept... |
|
2016
|
Invention
|
Polypeptide. 28D. The present disclosure also relates to the use of such a PD-L1 binding polypept... |
|
|
Invention
|
Polypeptide. 26LHD. The present disclosure also relates to the use of such a PD-L1 binding polype... |
|
|
Invention
|
New polypeptide. The present disclosure relates to a class of engineered polypeptides having a bi... |
|
|
Invention
|
New polypeptide having affinity to pd-l1. The present disclosure relates to a class of engineered... |
|
|
Invention
|
Polypeptide libraries with a predetermined scaffold. Populations of polypeptide variants based on... |
|
|
Invention
|
Alzheimer abeta peptide binding polypeptide.
The present disclosure relates to a class of engine... |
|
|
Invention
|
Alzheimer abeta peptide binding polypeptide. The present disclosure relates to a class of enginee... |
|
|
Invention
|
Binding polypeptides having a mutated scaffold. 47Q (SEQ ID NO: 55), and methods for selecting a ... |
|
|
Invention
|
Il-17a-binding polypeptides. 29. Also disclosed is the use of such an interleukin-17A binding pol... |
|
|
Invention
|
Il-17a-binding polypeptides. The present disclosure relates to a class of engineered polypeptides... |
|
2015
|
Invention
|
Vegfr-2 binding polypeptides. The present disclosure relates to a class of engineered polypeptide... |
|
|
Invention
|
Neonatal fc receptor binding dimer and methods of use. The present disclosure relates to dimers o... |
|
|
Invention
|
New polypeptides. The present disclosure relates to dimers of engineered polypeptides having a bi... |
|
|
Invention
|
Polypeptide. 29. The present disclosure also relates to the use of such an IL-6 binding polypepti... |
|
2014
|
Invention
|
Engineered albumin binding polypeptide. The present disclosure relates to a class of engineered p... |
|
|
Invention
|
Polypeptides. 29 (SEQ ID NO: 1075). The present disclosure also relates to the use of such an FcR... |
|
2013
|
Invention
|
Polypeptides. The present disclosure relates to a class of engineered polypeptides having a bindi... |
|
2005
|
P/S
|
Chemicals used in industry and science; chemical reagents (other than for medical or veterinary p... |
|
2002
|
P/S
|
Medicines for human purposes; medicines for veterinary purposes. Research and development (for ot... |
|
2001
|
P/S
|
Pharmaceutical preparations for the treatment of cancer, infectious diseases; diagnostic preparat... |
